ABIN954082
antibody from antibodies-online
Targeting: PEG10
HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN954082 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Paternally Expressed 10 (PEG10) (AA 1-30), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- Protein A column, followed by peptide affinity purification
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- N-Term, AA 1-30
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references [MiR-122 regulates the expression of PEG10 in hepatoma cell lines].
PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma.
Human retroviral gag- and gag-pol-like proteins interact with the transforming growth factor-beta receptor activin receptor-like kinase 1.
Chang Y, He XX, Li PY, Lin JS
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 2010 Apr;18(4):288-91
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 2010 Apr;18(4):288-91
PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma.
Tsuji K, Yasui K, Gen Y, Endo M, Dohi O, Zen K, Mitsuyoshi H, Minami M, Itoh Y, Taniwaki M, Tanaka S, Arii S, Okanoue T, Yoshikawa T
Cancer genetics and cytogenetics 2010 Apr 15;198(2):118-25
Cancer genetics and cytogenetics 2010 Apr 15;198(2):118-25
Human retroviral gag- and gag-pol-like proteins interact with the transforming growth factor-beta receptor activin receptor-like kinase 1.
Lux A, Beil C, Majety M, Barron S, Gallione CJ, Kuhn HM, Berg JN, Kioschis P, Marchuk DA, Hafner M
The Journal of biological chemistry 2005 Mar 4;280(9):8482-93
The Journal of biological chemistry 2005 Mar 4;280(9):8482-93
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS